Showing results (581-590 of 719) with videos related to
Sort By:
Pageof 72
Journal of Immunotoxicology|May 28, 2017
Human in situ cytokine and leukocyte responses to acute smokingTegan Kastelein, Rob Duffield, Frank MarinoJournal of Immunotoxicology|June 24, 2017
Evaluation of immunomodulatory effects of zearalenone in miceMohammad Rafiqul Islam, Jong Won Kim, Yoon-Seok Roh, et al.Journal of Immunotoxicology|November 18, 2009
Transforming growth factor-beta: a target for cancer therapyRonan J Kelly, John C MorrisJournal of Immunotoxicology|July 12, 2017
Genetics and immunodysfunction underlying Behçet's disease and immunomodulant treatment approachesArash Salmaninejad, Arezoo Gowhari, Seyedmojtaba Hosseini, et al.Journal of Immunotoxicology|July 6, 2018
Methoxychlor metabolite HPTE alters viability and differentiation of embryonic thymocytes from C57BL/6 miceLucie Leung-Gurung, Priscilla Escalante Cobb, Faraj Mourad, et al.Journal of Immunotoxicology|October 3, 2008
Use of an ex vivo local lymph node assay to assess contact hypersensitivity potentialJoseph R Piccotti, Thomas T KawabataJournal of Immunotoxicology|October 3, 2008
Alterations in CD4+, CD8+, Vgamma3, Vgammadelta, and/or Valpha betaT-lymphocyte expression in lymphoid tissues of progeny after in utero exposure to benzo(alpha)pyreneP Urso, Y G Wirsiy, W Zhang, et al.Journal of Immunotoxicology|October 3, 2008
Biodistribution and toxicological safety of adenovirus type 5 and type 35 vectored vaccines against human immunodeficiency virus-1 (HIV-1), Ebola, or Marburg are similar despite differing adenovirus serotype vector, manufacturer's construct, or gene insertsRebecca L Sheets, Judith Stein, Robert T Bailer, et al.Journal of Immunotoxicology|June 24, 2008
Changes in gene expression induced by carbamazepine and phenytoin: testing the danger hypothesisWei Lu, Xujian Li, Jack P UetrechtJournal of Immunotoxicology|June 24, 2008
Asbestos-induced autoimmunity in C57BL/6 miceJean C Pfau, Jami J Sentissi, Sheng'ai Li, et al.Pageof 72